508‑988‑0105 · info@axiomregenerative.us 375 Totten Pond Rd, Waltham, MA 02451
Technical training

Hands-on learning tied to the real process

Focused programs for scientists, operators, quality staff, and technical leaders working in cell-therapeutics development.

MSC culture & characterization

Isolation concepts, expansion, morphology, viability, identity, differentiation context, contamination controls, cryopreservation skills, and documentation.

Immune-cell workflows

Expansion principles, phenotype, functional assays, sample handling, process variability, and risk-aware interpretation.

Extracellular-vesicle research

Research-stage isolation choices, particle and marker characterization, controls, normalization, reproducibility, and reporting limits.

Aseptic processing & cleanroom behavior

Gowning, material flow, contamination control, environmental monitoring context, interventions, deviations, and operator qualification.

QC, release & potency strategy

Identity, purity, viability, safety testing, method suitability, specifications, reference materials, out-of-specification thinking, and potency.

Custom team training

A curriculum mapped to the organization’s process, SOPs, equipment, roles, quality system, and documented competency goals.

Training workflow

Define, practice, assess, document.

Training content should match the learner’s role and the controlled procedure they are expected to perform—not just a generic course outline.

Scope

Confirm learners, current capability, procedures, equipment, risks, desired competency, and evidence of completion.

Tailor

Build role-specific instruction, demonstrations, supervised practice, checks, and remediation criteria.

Deliver

Train in an appropriate environment with controlled materials, safety expectations, and documented observations.

Assess & follow up

Record completion and competency evidence, identify gaps, and define supervised practice or reassessment when needed.

Build the evidence and development plan before making the claim.

Tell us the modality, indication, development stage, and decision you need to make next.

Discuss a development program